Litigation Details for Highland Capital Management, L.P. - Adversary Proceeding (Bankr. N.D. Tex. 2021)
✉ Email this page to a colleague
Highland Capital Management, L.P. - Adversary Proceeding (Bankr. N.D. Tex. 2021)
Docket | ⤷ Try a Trial | Date Filed | 2021-01-21 |
Court | United States Bankruptcy Court, N.D. Texas | Date Terminated | |
Cause | Assigned To | Stacey G.C. Jernigan | |
Jury Demand | Referred To | ||
Patents | 10,413,539; 6,001,964; 6,011,007 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Highland Capital Management, L.P. - Adversary Proceeding
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Highland Capital Management, L.P. - Adversary Proceeding (Bankr. N.D. Tex. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-12-17 | 132 | approximately. I think maybe seven -- six, 11 seven years. 12 Q Okay. How about…not confirm 5 this plan because it is patently unconfirmable. Or if the 6 | External link to document | |
2021-05-24 | 29 | List (witness/exhibit/generic) | B 10,413,539.53 Affiliate Note Receivable ‐ C … (Where available) 60. Patents, copyrights, trademarks, and trade secrets 61 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |